{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-013823","form_type":"8-K","ticker":"PROK","cik":"0001850270","company_name":"PROKIDNEY CORP.","filed_at":"2024-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.009232+00:00","generated_at":"2026-06-06T04:28:07.391849+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"ProKidney grants supplemental stock option to Chief Legal Officer Todd Girolamo","bullets":["Option for 234,742 Class A ordinary shares at FMV on March 1, 2024 grant date.","Vesting: 50% on March 1, 2025; remainder in equal monthly installments over 12 months.","Award approved Feb 6, 2024 under 2022 Incentive Equity Plan for retention purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-013823","json":"https://secwatch.observer/filing/0000950170-24-013823.json","markdown":"https://secwatch.observer/filing/0000950170-24-013823.md","text":"https://secwatch.observer/filing/0000950170-24-013823.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024013823/0000950170-24-013823-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024013823/prok-20240206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T04:28:07.391849+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}